Synthesis and in vitro multidrug resistance modulating activity of a series of dihydrobenzopyrans and tetrahydroquinolines

Journal of Medicinal Chemistry

Volumn 42, Issue 11, 1999, Pages 1921-1926

  Hiessböck, Romana ^a   Wolf, Christian ^a   Richter, Elisabeth ^a   Hitzler, Manuela ^a   Chiba, Peter ^a   Kratzel, Martin ^a   Ecker, Gerhard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPYRAN DERIVATIVE; DAUNORUBICIN; GLYCOPROTEIN P; NITROGEN; PROPAFENONE; QUINOLINE DERIVATIVE; VERAPAMIL;

ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSPORT; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TRANSPORT KINETICS;

ANTIBIOTICS, ANTINEOPLASTIC; CHROMANS; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; HUMANS; P-GLYCOPROTEIN; QUINOLINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0038698323     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980517+     Document Type: Article

References (21)

1. Biedler, J. L.; Chang, T.; Meyers, M. B.; Peterson, F. H.; Spengler, B. A. Drug Resistance in Chinese Hamster Lung and Mouse Tumor Cells. Cancer Treatment Rep. 1983, 67, 859-867.
2. Bradley, G.; Juranka, P. F.; Ling, V. Mechanism of Multidrug Resistance. Biochim. Biophys. Acta 1988, 948, 87-128.
3. Gottesman, M. M.; Pastan, I. Biochemistry of Multidrug Resistance Mediated by the Multidrug Transporter. Annu. Rev. Biochem. 1993, 62, 385-427.
4. Ford, J. M. Experimental Reversal of P-glycoprotein Mediated Multidrug Resistance by Pharmacological Chemosensitizers. Eur. J. Cancer 1996, 32A, 991-1001.
5. Ecker, G.; Chiba, P. Strucutreactivity Relationship Studies on Modulators of the Multidrug Transporter P-glycoprotein - an Overview. Wien. Klin. Wochenschr. 1995, 107, 681-686.
6. Seelig, A. A General Pattern for Substrate Recognition by P-glycoprotein. Eur. J. Biochem. 1998, 251, 252-261.
7. Godfrey, J. D.; Mueller, R. H.; Sedergran, T. C.; Soundararajan, N.; Colandrea, V. J. Improved Synthesis of Aryl 1,1-Dimethylpropargyl Ethers. Tetrahedron Lett. 1994, 35, 6405-6408.
8. Ashwood, V. A.; Cassidy, F.; Coldwell, M. C.; Evans, J. M.; Hamilton, T. C.; Howlett, D. R.; Smith, D. M.; Stemp, G. Synthesis and Antihypertensive Activity of 4-(Substituted-carbonylamino)-2H-benzopyrans. J. Med. Chem. 1990, 33, 2667-2672.
9. Kratzel, M.; Hiessböck, R.; Völlenkle, H. Synthesis and Stereochemistry of 1-Acyl-2-alkyl-1,2,3,4-tetrahydroquinoline-3,4-epoxides. Monatsh. Chem. 1994, 125, 963-969.
10. Buckle, D. R.; Eggleston, D. S.; Houge-Frydrych, C. S. V.; Pinto, I. L.; Readshaw, S. A.; Smith, D. G.; Webster, R. A. B. Conformational and Steric Modifications of the Pyran Ring of the Potassium-Channel Activator Cromakalim. J. Chem. Soc., Perkin Trans, 1, 1991, 2763-2771.
11. Kratzel, M.; Hiessböck, R. 1-Acyl-2-alkyl-3,4-epoxy-1,2,3,4-tetrahydroquinolines-Synthesis and Reactions with N-Nucleophiles. Heterocycles 1995, 41, 897-909.
12. Ghose, A. K.; Pritchett, A.; Crippen, G. M. Atomic Physicochemical Parameters for Three-Dimensional Structure Directed Quantitative Structure-Activity Relationships III: Modeling Hydrophobic Interactions. J. Comput. Chem. 1988, 9, 80-90.
13. MOLGEN 3.0. Copyright 1994 by Baricic, P.; Mackov, M. Distributed by CHERS, c/o Milan Hudecek, P. Horova 18, SK-841 07 Bratislava, Slovakia.
14. Prets, S.; Jungreithmair, A.; Chiba, P.; Ecker, G. Comparison of Different Methods for Estimation of Lipophilicity of Propafenone-Type Modulators of Multidrug Resistance. Sci. Pharm. 1996, 64, 627-636.
15. Chiba, P.; Ecker, G.; Schmid, D.; Drach, J.; Tell, B.; Gekeler, V. Structural Requirements for Activity of Propafenone Type Modulators in PGP-Mediated Multidrug Resistance. Mol. Pharmacol. 1996, 49, 1122-1130.
16. Gekeler, V.; Frese, G.; Noller, A.; Handgretinger, R.; Wilisch, A.; Schmidt, H.; Muller, D.; Dopfer, R.; Klingbiel, T.; Diddens, H.; Probst, H.; Niethammer, D. Mdr1/P-glycoprotein, Topoisomerase and Glutathione S-transferase Gene Expression in Primary and Relapsed State Adult and Childhood Leukemias. Br. J. Cancer 1992, 66, 507-517.
17. Chiba, P.; Holzer, W.; Landau, M.; Bechmann, G.; Lorenz, K.; Plagens, B.; Hitzler, M.; Richter, E.; Ecker, G. Substituted 4-Acylpyrazoles and 4-Acylpyrazolones: Synthesis and Multidrug Resistance-Modulating Activity. J. Med. Chem. 1998, 41, 4001-4011.
18. Ecker, G.; Chiba, P.; Hitzler, M.; Schmid, D.; Visser, K.; Cordes, H. P.; Csöllei, J.; Seydel, J. K.; Schaper, K.-J. Structure-Activity Relationship Studies on Benzofurane Analogues of Propafenone-Type Modulators of Tumor Cell Multidrug Resistance. J. Med. Chem. 1996, 39, 4767-4774.
19. Tmej, C.; Chiba, P.; Huber, M.; Richter, E.; Hitzler, M.; Schaper, K.-J.; Ecker, G. A Combined Hansch/Free-Wilson Approach as Predictive Tool in QSAR Studies on Propafenone-Type Modulators of Multidrug Resistance. Arch. Pharm. Pharm. Med. Chem. 1998, 331, 233-240.
20. Ohtuka, K.; Ishiyama, N.; Iida, Y.; Seri, K.; Murai, T.; Sanai, K.; Ishizaka, Y. Preparation of 6-cyano-2,2-dimethyl-4-[(N-cyanoimidoyl)amino]-2H-benzo[b]pyrans and analogues as antihypertensives and bronchodilators. Eur. Pat. Appl. EP 412,531 (Cl. C07D311/68), 13 Feb. 1991. Abstract in: Chem. Abstr. 1991, 115, 49406u.
21. Gekeler, V.; Weger, S.; Probst, H. Mdr1/P-Glycoprotein Gene Segments Analyzed from Various Human Leukemic Cell Lines Exhibiting Different Multidrug Resistance Profiles. Biochem. Biophys. Res. Commun. 1990, 169, 796-802.